<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">While there is, at this time, little evidence that SARS-CoV-2 enters the brain parenchyma, there are multiple means by which the virus might be able to do so
 <sup>
  <xref ref-type="bibr" rid="CR75">75</xref>
 </sup>. Preclinical animal studies (reviewed by Natoli et al.
 <sup>
  <xref ref-type="bibr" rid="CR76">76</xref>
 </sup>) report that after intranasal inoculation of SARS‐CoV in transgenic mice that overexpress human ACE2
 <sup>
  <xref ref-type="bibr" rid="CR77">77</xref>
 </sup>, or MERS-CoV in mice overexpressing human dipeptidyl peptidase 4
 <sup>
  <xref ref-type="bibr" rid="CR78">78</xref>
 </sup>, SARS‐CoV and MERS-CoV can invade the brain, possibly via transit through the olfactory nerves, to reach CNS nuclei, including thalamus and brainstem; we note, however, that these mice over-express the viral receptors, and these reports do not model normal infection routes.
</p>
